Bristol-Myers Squibb Co.
BMY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
$BMY is featured in our Lobbying Spending Growth and Tom Carper strategies.
All StrategiesIncome
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of BMY by members of U.S. Congress
BMY Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
BMY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
BMY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BMY holdings by institutional investors
Quarterly net insider trading by BMY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$3,160,000 Jul 20, 2026 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,320,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$1,250,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$3,180,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$4,780,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$870,000 Apr 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy
-
$790,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$3,250,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$640,000 Jul 22, 2024 Issue: Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$80,000 May 28, 2024 Issue: Medicare/Medicaid Health Issues
-
$2,060,000 Jan 21, 2024 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,180,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,230,000 Jul 19, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$640,000 Jan 20, 2023 Issue: Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$870,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,590,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$2,300,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$730,000 Feb 07, 2022 Issue: None
-
$710,000 Jan 20, 2022 Issue: None
-
$1,740,000 Oct 20, 2021 Issue: None
-
$2,230,000 Jul 20, 2021 Issue: None
-
$1,090,000 May 17, 2021 Issue: None
-
$730,000 Apr 20, 2021 Issue: None
-
$1,600,000 Oct 19, 2020 Issue: None
-
$2,160,000 Jul 20, 2020 Issue: None
-
$540,000 Apr 20, 2020 Issue: None
-
$690,000 Jan 17, 2020 Issue: None
-
$1,240,000 Oct 17, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$970,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,200,000 Apr 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$940,000 Jan 18, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$960,000 Oct 19, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,130,000 Jul 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$800,000 Apr 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$860,000 Jan 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$900,000 Oct 18, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$860,000 Jul 17, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
-
$990,000 Apr 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$560,000 Jan 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$670,000 Nov 29, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
-
$810,000 Oct 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$690,000 Apr 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$780,000 Jan 18, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$850,000 Oct 19, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$670,000 Jul 20, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$610,000 Apr 17, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$770,000 Jan 16, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$680,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$775,000 Jul 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$520,000 Apr 17, 2014 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$740,000 Jan 17, 2014 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$542,000 Oct 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$724,000 Jul 16, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$830,000 Apr 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$1,280,000 Jan 22, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$520,000 Oct 17, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$820,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$660,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$870,000 Jan 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$660,000 Oct 18, 2011 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$560,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$1,040,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$509,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$795,000 Oct 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$980,000 Jul 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,060,000 Apr 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$860,000 Apr 19, 2010 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$952,580 Oct 20, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products Welfare
-
$809,000 Jul 16, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Welfare
-
$814,676 Apr 17, 2009 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,025,520 Jan 21, 2009 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$840,000 Oct 16, 2008 Issue: Law Enforcement/Crime/Criminal Justice Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Clean Air and Water (quality)
-
$830,000 Jul 21, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medical/Disease Research/Clinical Labs
-
$840,000 Apr 18, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$2,660,000 Mar 12, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Copyright/Patent/Trademark
-
$2,840,000 Sep 17, 2007 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations
-
$2,980,000 Feb 12, 2007 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$2,760,000 Aug 10, 2006 Issue: Advertising Clean Air and Water (quality) Torts Medical/Disease Research/Clinical Labs Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Energy/Nuclear Telecommunications Foreign Relations Food Industry (safety, labeling, etc.) Labor Issues/Antitrust/Workplace Law Enforcement/Crime/Criminal Justice
-
$2,580,000 Feb 14, 2006 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$2,460,000 Aug 11, 2005 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Torts
-
$2,860,000 Feb 11, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Government Issues Torts
-
$2,720,000 Aug 13, 2004 Issue: Health Issues Foreign Relations Clean Air and Water (quality) Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Food Industry (safety, labeling, etc.) Torts
-
$2,740,000 Feb 12, 2004 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Trade (domestic/foreign)
-
$2,580,000 Aug 07, 2003 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Government Issues Consumer Issues/Safety/Products Insurance Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations
-
$2,420,000 Mar 14, 2003 Issue: None
-
$2,480,000 Aug 01, 2002 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Copyright/Patent/Trademark Telecommunications Taxation/Internal Revenue Code Health Issues Foreign Relations Consumer Issues/Safety/Products Medicare/Medicaid Budget/Appropriations Environment/Superfund Insurance Economics/Economic Development Trade (domestic/foreign)
-
$2,400,000 Feb 14, 2002 Issue: Foreign Relations Health Issues Medicare/Medicaid Telecommunications Copyright/Patent/Trademark Economics/Economic Development Budget/Appropriations Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Labor Issues/Antitrust/Workplace Pharmacy Medical/Disease Research/Clinical Labs Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$2,460,000 Aug 14, 2001 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Consumer Issues/Safety/Products Insurance Foreign Relations Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Telecommunications Budget/Appropriations Environment/Superfund
-
$2,220,000 Aug 01, 2001 Issue: Law Enforcement/Crime/Criminal Justice Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Consumer Issues/Safety/Products Government Issues Clean Air and Water (quality)
-
$2,440,000 Aug 10, 2000 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Foreign Relations Medicare/Medicaid Trade (domestic/foreign) Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice
-
$2,020,000 Feb 10, 2000 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Government Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Consumer Issues/Safety/Products Energy/Nuclear
-
$1,600,000 Aug 10, 1999 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice
Former government officials who have lobbied for BMY
44 former government officials from 27 congressional offices at 13 lobbying firms have lobbied for BMY, most recently Aug 04, 2026.
-
Matthew Mcginley House New Chief of Staff, Rep. Tom Price; Chief of Staff, Republican Policy Committee; DCOS & LD, Rep. Brian Kerns -
Paul Brathwaite Congress Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.
-
Ven Neralla House New Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC. -
Kaade Wallace Senate New Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum -
Stacey Leavandosky House New Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation -
Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker -
Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
-
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
BMY Estimated quarterly lobbying spending
BMY Revenue by Segment or Geography
By Segment
By Geography
BMY Income Statement
BMY Balance Sheet
BMY Cash Flow
U.S. Patents
New BMY patent grants
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 23, 2024
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 02, 2024
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Mar. 26, 2024
-
Patent Title: Oxazolidinones as modulators of mglur5 Nov. 28, 2023
-
Patent Title: Substituted nitrogen containing compounds Oct. 17, 2023
-
Patent Title: Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists Jan. 03, 2023
-
Patent Title: Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifnα responses Apr. 07, 2020
-
Patent Title: Hepatitis c virus inhibitors May. 02, 2017
-
Patent Title: Modified fgf-21 polypeptides comprising an internal deletion and uses thereof Apr. 25, 2017
-
Patent Title: Macrocyclic compounds as hcv entry inhibitors Apr. 18, 2017
-
Patent Title: Ido inhibitors Apr. 18, 2017
-
Patent Title: Squaric derivatives for the treatment of hepatitis c Apr. 18, 2017
-
Patent Title: Imidazooxadiazole compounds Apr. 11, 2017
-
Patent Title: Five-membered heterocycles useful as serine protease inhibitors Apr. 11, 2017
-
Patent Title: Macrocycles as factor xia inhibitors Apr. 04, 2017
-
Patent Title: Antibodies against cd73 Mar. 28, 2017
-
Patent Title: Protein scaffolds for antibody mimics and other binding proteins Mar. 28, 2017
-
Patent Title: Par4 agonist peptides Mar. 28, 2017
-
Patent Title: Dihydropyrazole gpr40 modulators Mar. 28, 2017
-
Patent Title: Iap antagonists Mar. 28, 2017
-
Patent Title: Substituted bicyclic heteroaryl compounds Mar. 21, 2017
-
Patent Title: Hepatitis c virus inhibitors Mar. 21, 2017
-
Patent Title: Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine derivatives as casein kinase 1 d/e inhibitors Mar. 21, 2017
-
Patent Title: Crystalline form of Mar. 21, 2017
-
Patent Title: Bicyclo[2.2.2]acid gpr120 modulators Mar. 21, 2017
-
Patent Title: Sensitive method to analyse free peg-maleimide Mar. 14, 2017
-
Patent Title: Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders Mar. 14, 2017
-
Patent Title: Crystalline forms of n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders Mar. 14, 2017
-
Patent Title: Imide and acylurea derivatives as modulators of the glucocorticoid receptor Mar. 14, 2017
-
Patent Title: Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists Mar. 07, 2017
-
Patent Title: Hepatitis c virus inhibitors Feb. 28, 2017
-
Patent Title: Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors Feb. 28, 2017
-
Patent Title: Fibronectin based scaffold proteins having improved stability Feb. 07, 2017
-
Patent Title: Hepatitis c virus inhibitors Feb. 07, 2017
-
Patent Title: Methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1r,5s)-3-methyl-3,8-diazabicyclo [3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide Jan. 31, 2017
-
Patent Title: Substituted imidazoles as casein kinase 1 d/e inhibitors Jan. 31, 2017
-
Patent Title: Imidazotriazinecarbonitriles useful as kinase inhibitors Jan. 31, 2017
-
Patent Title: Compound for the treatment of hepatitis c Jan. 31, 2017
-
Patent Title: Polycyclic lpa1 antagonist and uses thereof Jan. 31, 2017
-
Patent Title: Hepatitis c virus inhibitors Jan. 17, 2017
-
Patent Title: Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators Jan. 17, 2017
-
Patent Title: Mammalian cell culture processes for protein production Jan. 10, 2017
-
Patent Title: Serum albumin binding molecules Jan. 10, 2017
-
Patent Title: Alkyl amide-substituted pyrimidine compounds useful in the modulation of il-12, il-23 and/or ifnα Jan. 10, 2017
-
Patent Title: 7-hydroxy-indolinyl antagonists of p2y Jan. 10, 2017
-
Patent Title: Hepatitis c virus inhibitors Dec. 27, 2016
-
Patent Title: Benzodiazepine dimers, conjugates thereof, and methods of making and using Dec. 27, 2016
-
Patent Title: Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method Apr. 30, 2013
-
Patent Title: Epothilone derivatives Dec. 06, 2011
-
Patent Title: Aziridinyl-epothilone compounds Nov. 15, 2011
Government Contracts
Federal grants, loans, and purchases
- $0 2026-08-27 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-08-06 00:00:00 Agency: Department of Veterans Affairs
- $378,650 2026-08-06 00:00:00 Agency: Department of Veterans Affairs
- $51,333 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $300,000 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $199,047 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-07-31 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-07-15 00:00:00 Agency: Department of Veterans Affairs
- $138,257 2026-07-07 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-07-07 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-30 00:00:00 Agency: Department of Veterans Affairs
- $11,977 2026-06-26 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-06-18 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-06-15 00:00:00 Agency: Department of Veterans Affairs
- $16,768 2026-06-11 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-02 00:00:00 Agency: Department of Veterans Affairs
- $11,977 2026-05-29 00:00:00 Agency: Department of Veterans Affairs
- $149,436 2026-05-29 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-05-27 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-05-21 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-05-21 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-14 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-08 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-08 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-05-07 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $138,603 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $5,814 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-04-24 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-04-23 00:00:00 Agency: Department of Veterans Affairs
- $11,319 2026-04-20 00:00:00 Agency: Department of Justice
- $11,319 2026-04-20 00:00:00 Agency: Department of Justice
- $10,888 2026-04-16 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $138,694 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $0 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-03-20 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-03-20 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-03-09 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-03-09 00:00:00 Agency: Department of Veterans Affairs
- $5,814 2026-03-06 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-03-05 00:00:00 Agency: Department of Veterans Affairs
- $127,169 2026-02-26 00:00:00 Agency: Department of Veterans Affairs
- $338,933 2026-02-19 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
- $33,190 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
- $183,452 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
Government Contracts
Estimated quarterly amount awarded to BMY from public contracts
BMY News
Recent insights relating to BMY
CNBC Recommendations
Recent picks made for BMY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BMY
BMY Analyst Ratings
BMY Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
BMY Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $BMY stock a Buy, Sell, or Hold?
- What is the price target for $BMY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
BMY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $BMY stock?
- Who owns the most shares of $BMY stock?
- What funds own $BMY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
BMY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BMY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About BMY
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Address Princeton, NJ
- Market Cap 130.9 billion
- Employees 32,500
- Industrial Classification Pharmaceutical Preparations
Bristol-Myers Squibb Co. Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at BMY, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|